Construction of eukaryotic expression plasmid of hTGF-β3 and its inducing effect on differentiation of precartilaginous stem cells into chondroblasts

Abstract

This study examined the construction of eukaryotic expression plasmid of human transforming growth factor-β3 (hTGF-β3) and its inducing effect on the differentiation of precartilaginous stem cells (PSCs) into chondroblasts. hTGF-β3 gene was amplified by using polymerase chain reaction (PCR) and then inserted into the eukaryotic expression plasmid pcDNA3.1 to construct the eukaryotic expression plasmid pcDNA3.1(+)-hTGF-β3. Rat PSCs were isolated and purified by employing an immunomagnetic cell sorting system. pcDNA3.1(+)-hTGF-β3 was transfected into purified PSCs with the use of linear polyamines. The expression of TGF-β3 and cartilage-specific extracellular matrix (ECM) components was detected after transfection by real-time quantitative PCR, ELISA, immunochemistry and Western blotting, respectively. The results showed that the eukaryotic expression plasmid pcDNA3.1(+)-hTGF-β3 was successfully established as identified by enzyme digestion and DNA sequencing. Real-time quantitative PCR and ELISA revealed that hTGF-β3 was strongly expressed in pcDNA3.1(+)-hTGF-β3-transfected PSCs. Real-time quantitative PCR, immunochemistry and Western blotting showed that the cartilage-specific ECM markers, i.e., cartilage oligomeric matrix protein (COMP), Aggrecan, collagen type X and II were intensely expressed in the pcDNA3.1(+)-hTGF-β3-transfected cells. It was concluded that hTGF-β3 could be stably expressed in pcDNA3.1(+)-hTGF-β3-transfected PSCs and induce the differentiation of PSCs into chondroblasts.

Keywords

TGF-β / plasmid / stem cell / gene transfection / cartilagenesis

References

[1] ThirionS., BerenbaumF.. Culture and phenotyping of chondrocytes in primary culture. Methods Mol Med, 2004, 100: 1-14

[2] RobinsonD., HasharoniA., CohenN., et al.. Fibroblast growth factor receptor-3 as a marker for precartilaginous stem cells. Clin Orthop, 1999, 367(Suppl): S163-S175

[3] MassaguéJ., HataA., LiuF.. TGF-β signaling through the Smad pathway. Trends Cell Biol, 1997, 7(5): 187-192

[4] MosesL., SerraR.. Regulation of differentiation by TGF-β. Curr Opin Gen Dev, 1996, 6(5): 581-586

[5] HoodlessA., WranaL.. Mechanism and function of signaling by the TGF-β superfamily. Curr Top Microbiol Immunol, 1998, 228: 235-272

[6] YouH.B., ChenA.M.. Transfection of precartilaginous stem cells with enhanced green fluorescence protein gene and transforming growth factor β3 inducing chondrogenesis in precartilaginous stem cells. Chin J Pediatr Sur (Chinese), 2004, 25(6): 545-549

[7] YouH.B., ChenA.M., ChengH.. Immunomagnetic separation to isolate and purify precartilaginous stem cells from neonate rats. Chin J Trauma (Chinese), 2004, 20(10): 33-35

[8] LivakK.J., SchmittgenT.D.. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 2001, 25(4): 402-408

[9] ChubinskayaS., KuettnerK.E.. Regulation of osteogenic proteins by chondrocytes. Int J Biochem Cell Biol, 2003, 35(9): 1323-1340

[10] van den BergW.B., van der KraanP.M., ScharstuhlA., et al.. Growth factors and cartilage repair. Clin Orthop, 2001, 391(Suppl): S244-S250

[11] GrimaudE., HeymannD.. Redini F. Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disorders. Cytokine Growth Factor Rev, 2002, 13(3): 241-257

[12] MiyazonoK.. TGF-beta signaling by Smad proteins. Cytokine Growth Factor Rev, 2000, 11(1–2): 15-22

[13] CoxD.A.. Transforming growth factor-beta 3. Cell Biol Int, 1995, 19(5): 357-371

[14] RobertsA.B., KondaiahP., RosaF., et al.. Mesoderm induction in Xenopus laevis distinguishes between the various TGF-beta isoforms. Growth Factors, 1990, 3(4): 277-286

[15] BostromM.P., AsnisP.. Transforming growth factor beta in fracture repair. Clin Orthop, 1998, 355(Suppl): S124-S131

[16] HosokawaR., NonakaK., MorifujiM., et al.. TGF-beta 3 decreases type I collagen and scarring after labioplasty. J Dent Res, 2003, 82(7): 558-564

[17] NaK., KimS., WooD.G., et al.. Synergistic effect of TGFbeta-3 on chondrogenic differentiation of rabbit chondrocytes in thermo-reversible hydrogel constructs blended with hyaluronic acid by in vivo test. J Biotechnol, 2007, 128(2): 412-422

[18] O’KaneS., FergusonM.W.. Transforming growth factor betas and wound healing. Int J Biochem Cell Biol, 1997, 29(1): 63-78

[19] FlandersK.C., BurmesterJ.K.. Medical applications of transforming growth factor-beta. Clin Med Res, 2003, 1(1): 13-20

[20] ZhangA.G., DongQ.R.. Research advances in gene-enhanced cartilage tissue-engineering. Chin J Orthop Trauma (Chinese), 2005, 7(5): 476-479

[21] GebhartC.L., KabanovA.V.. Evaluation of polyplexes as gene transfer agents. J Control Release, 2001, 73(2–3): 401-416

[22] LungwitzU., BreunigM., BlunkT., et al.. Polyethyleni mine-based non-viral gene delivery systems. Eur J Pharm Biopharm, 2005, 60(2): 247-266

[23] DavidA.. Transforming growth factor-beta3. Cell Biol Int, 1995, 19(5): 357-371

[24] ZauckeF., DinserR., MaurerP., et al.. Cartilage oligomeric matrix protein (COMP) and collagen IX are sensitive markers for the differentiation state of articular primary chondrocytes. Biochem J, 2001, 358(1): 17-24